Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Coronary Heart Disease | Research

Prognosis of coronary heart disease after percutaneous coronary intervention: a bibliometric analysis over the period 2004–2022

Authors: Shiyi Tao, Xianwen Tang, Lintong Yu, Lingling Li, Gaoyu Zhang, Lanxin Zhang, Li Huang, Jiayun Wu

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

As the complexity and diversity of the percutaneous coronary intervention (PCI) are being explored and reported, burgeoning research has progressed in this field. However, there is no comprehensive analysis available on PCI-related studies published in the literature. This study aimed to analyze and visualize the changes of scientific output regarding prognosis of coronary heart disease (CHD) after PCI over the past 20 years and to reveal the knowledge domain and development trends in this field by using CiteSpace software.

Methods

Relevant articles published over the period 2004–2022 were retrieved from the Web of Science Core Collection database. After manual selection, qualified documents were included and recorded with the information of their title, abstract, keyword, author, descriptor, citation, identifier, publishing year and publishing organization. We transferred the data to CiteSpace V5.8.R2 (Version 5.8.R2) to draw knowledge maps and to conduct co-occurrence analysis, cluster analysis, timeline analysis, burst term detection and citation analysis.

Results

A total of 14,699 literature records were found relating prognosis of CHD after PCI in the past 20 years (2004–2022), including 14,212 original articles and reviews, and they were published in 153 different journals. Publication production has increased annually and a total of 1182 authors, 796 institutes and 147 countries have contributed to these publications. Moreover, the most representative author was Gregg W Stone from the CardioVascular Research Foundation (CVRF) with 368 publications, whose team mainly focused on exploring the efficacy and safety of revascularization and the characteristics of susceptible population. The global productivity ranking was led by the USA with 3326 published papers, followed by Italy (n = 1355), Japan (n = 1080), China (n = 1075) and Germany (n = 937). And the keywords of these publications were “percutaneous coronary intervention” (n = 2271), “outcome” (n = 1756), “mortality” (n = 1730) and “impact” (n = 1334). Other commonly-used words were “predictor” (n = 1324), “intervention” (n = 1310), “angioplasty” (n = 1299), “risk” (n = 1144), “acute myocardial infarction” (n = 1136) and “artery disease” (n = 1098). Cluster analysis showed that 15 high connected clusters were generated with a modularity Q of 0.831 and a weighted mean silhouette of 0.9388 by applying the log-likelihood ratio algorithm, and the top 5 clusters were #0 optical coherence tomography, #1 dual antiplatelet therapy, #2 bleeding, #3 clopidogrel and #4 thrombus aspiration. Furthermore, the frontiers in the field of prognosis of CHD after PCI mainly involved “decision making”, “reperfusion”, “angioplasty”, “balloon”, “unstable angina”, “dual antiplatelet therapy”, “cardiac surgical score”, “restenosis”, “reperfusion”, “thrombolytic therapy”, etc.

Conclusions

To sum up, efficacy and safety of different types of stents, the risk factors of restenosis and thrombotic events after PCI, early risk assessment, and secondary prevention and complications of patients with CHD after PCI were research hotspots and frontier topics in the area by bibliometric analysis. The results could provide a comprehensive overview of the research hotspots and frontier topics relating prognosis of CHD after PCI, promoting a better understanding of the knowledge domain and development trends in this field during the past 20 years.
Literature
2.
go back to reference GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–544. https://doi.org/10.1016/S0140-6736(16)31012-1.CrossRef GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–544. https://​doi.​org/​10.​1016/​S0140-6736(16)31012-1.CrossRef
5.
go back to reference Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:197–215. https://doi.org/10.1016/j.jacc.2021.09.005. (Erratum in: J Am Coll Cardiol. 2022 Apr 19;79(15):1547).CrossRefPubMed Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:197–215. https://​doi.​org/​10.​1016/​j.​jacc.​2021.​09.​005. (Erratum in: J Am Coll Cardiol. 2022 Apr 19;79(15):1547).CrossRefPubMed
19.
go back to reference Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619. https://doi.org/10.1093/eurheartj/ehs215.CrossRef Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619. https://​doi.​org/​10.​1093/​eurheartj/​ehs215.CrossRef
21.
go back to reference Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, ESC Scientific Document Group, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2016;37:267–315. https://doi.org/10.1093/eurheartj/ehv320.CrossRefPubMed Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, ESC Scientific Document Group, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2016;37:267–315. https://​doi.​org/​10.​1093/​eurheartj/​ehv320.CrossRefPubMed
22.
go back to reference Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol. 2011;58:e44-122. https://doi.org/10.1016/j.jacc.2011.08.007.CrossRefPubMed Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol. 2011;58:e44-122. https://​doi.​org/​10.​1016/​j.​jacc.​2011.​08.​007.CrossRefPubMed
23.
go back to reference Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J. 2014;35:2541–619. https://doi.org/10.1093/eurheartj/ehu278.CrossRef Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J. 2014;35:2541–619. https://​doi.​org/​10.​1093/​eurheartj/​ehu278.CrossRef
35.
go back to reference Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Executive group on behalf of the joint European society of cardiology (ESC)/American college of cardiology (ACC)/American heart association (AHA)/world heart federation (WHF) task force for the universal definition of myocardial infarction. fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–51. https://doi.org/10.1161/CIR.0000000000000617. (Erratum in: Circulation. 2018 Nov 13;138(20):e652).CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Executive group on behalf of the joint European society of cardiology (ESC)/American college of cardiology (ACC)/American heart association (AHA)/world heart federation (WHF) task force for the universal definition of myocardial infarction. fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–51. https://​doi.​org/​10.​1161/​CIR.​0000000000000617​. (Erratum in: Circulation. 2018 Nov 13;138(20):e652).CrossRefPubMed
36.
go back to reference Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, RAVEL Study Group, et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80. https://doi.org/10.1056/NEJMoa012843.CrossRefPubMed Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, RAVEL Study Group, et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80. https://​doi.​org/​10.​1056/​NEJMoa012843.CrossRefPubMed
38.
39.
go back to reference Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957–66. https://doi.org/10.1056/NEJMoa013404.CrossRefPubMed Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957–66. https://​doi.​org/​10.​1056/​NEJMoa013404.CrossRefPubMed
43.
go back to reference Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, et al. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. Lancet. 2020;396:1079–89. https://doi.org/10.1016/S0140-6736(20)31791-8.CrossRefPubMed Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, et al. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. Lancet. 2020;396:1079–89. https://​doi.​org/​10.​1016/​S0140-6736(20)31791-8.CrossRefPubMed
Metadata
Title
Prognosis of coronary heart disease after percutaneous coronary intervention: a bibliometric analysis over the period 2004–2022
Authors
Shiyi Tao
Xianwen Tang
Lintong Yu
Lingling Li
Gaoyu Zhang
Lanxin Zhang
Li Huang
Jiayun Wu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01220-5

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue